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Acute neurological complications during coro-
nary angiography (CAG) are extremely uncommon 
with an incidence of < 0.1% [1] but they remain 
a challenging clinical problem, particularly in 
patients with acute coronary syndrome. Peripro-
cedural ischemic or hemorrhagic stroke remains 
the most common cause with an incidence of 
0.07–0.38% and is associated with high rates of 
morbidity and mortality [2]. However, sudden-on-
set neurological symptoms during diagnostic CAG 
or percutaneous coronary intervention (PCI) may 
result from rarer albeit fatal neurological or endo-
crine conditions, such as seizure, encephalopathy, 
contrast media-induced neurotoxicity or acute 
thyrotoxicosis [3]. Thyroid storm (TS) is a life-
-threatening endocrine emergency that represents 
the extreme manifestation of acute thyrotoxicosis 
and is associated with high morbidity and mortality 
(10%) rates if left untreated [3, 4]. 
Herein is reported a 70-year-old woman with 
arterial hypertension, pacemaker implantation for 
sick sinus syndrome and paroxysmal atrial fibril-
lation on long-term amiodarone therapy, who was 
admitted to the emergency department with acute 
typical chest pain. The patient underwent previous 
coronary artery bypass grafting with left internal 
mammary artery (LIMA) to the left anterior de-
scending artery (LAD) and saphenous vein graft 
to the right coronary artery (RCA) 16 years earlier, 
followed by PCI to the distal RCA with a drug-
eluting stent 9 years later. Three weeks prior to 
admission, the patient presented with weight loss, 
tremor and palpitations suggestive of thyrotoxico-
sis, with decreased levels of thyroid stimulating 
hormone (< 0.005 mIU/L, normal range 0.4– 
–4.0 mIU/L), and elevated levels of free thyroxine 
(T4) (93 pmol/L, normal range 11–27 pmol/L) and free 
tri-iodothyronine (T3) (16.5 pmol/L, normal range 
0.8–2.7 pmol/L), suggestive of amiodarone-induced 
thyrotoxicosis (anti-TSH receptor antibody: < 3 U/L). 
Amiodarone therapy was discontinued and an 
antithyroid drug (carbimazole 20 mg/day) was 
initiated with reduction of free T4 (70 pmol/L) 
and T3 (15 pmol/L) levels at 3-week follow-up. 
The thyroid ultrasound showed a slightly enlarged 
and heterogeneous thyroid gland, but excluded 
a nodular formation as well as hypervascularisa-
tion. Upon present admission, electrocardiogram 
demonstrated ST-segment depression from V3 to 
V6 leads and cardiac biomarkers were elevated. 
The CAG demonstrated a 3-vessel coronary artery 
disease with occlusion of the saphenous vein graft 
to RCA, involution of the LIMA graft to LAD, 50% 
distal left main coronary artery stenosis, obtuse 
marginal branches and intermediate artery sten-
oses, 50% distal RCA in-stent restenosis, and 
hemodynamically significant proximal LAD ste-
nosis. The patient underwent PCI to the proximal 
LAD with a drug-eluting stent. During the pro-
cedure, the patient developed acute neurological 
symptoms including headache, agitation, delirium, 
confusion, nausea and vomiting, that required 
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premature interruption of the procedure. Urgent 
physical examination showed no focal neurological 
symptoms, but revealed fever (38.5o) and sinus 
tachycardia (110 bpm). An urgent cerebral com-
puted tomography scan excluded acute intracranial 
hemorrhage or ischemic stroke. Electroencephalo-
gram showed moderate and diffuse encephalopathy 
without irritative pattern. Acute thyrotoxicosis 
with TS precipitated by iodinated contrast media 
administration during PCI was suspected. Clinical 
presentation was meeting the diagnostic criteria 
of the Japan Thyroid Association and the Burch 
and Wartofsky’s score was 55 points. Immediate 
therapy was initiated including intravenous hydro-
cortisone, metoprolol and increase of carbimazole 
dosage. The clinical course was favourable with 
total regression of neurological manifestations on 
the following day and progressive decrease of free 
T4 and T3 levels (Fig. 1).
Acute TS is an extremely rare hypermetabolic 
condition induced by excessive thyroid hormones 
release in individuals with thyrotoxicosis with 
an annual incidence of 2/1,000,000 patients, but 
it remains associated with high mortality rates 
(10–30%) [3, 4]. TS is a clinical diagnosis consid-
ering the absence of absolute circulating thyroid 
hormones levels cut-off and usually occurs follow-
ing a precipitating event in patients with severe 
thyrotoxicosis or previously undiagnosed hyper-
thyroidism [3]. TS results from sudden inhibition of 
thyroid hormone binding to plasma proteins leading 
to further increase in thyroid hormone levels. The 
main precipitating factors include irregular use 
or discontinuation of antithyroid drugs as well as 
iodinated contrast media administration. However, 
no clear trigger may be identified in 25–43% of 
patients [3]. The Burch and Wartofsky’s score is 
a scoring system based on clinical features proposed 
to guide the diagnosis of TS, particularly when thy-
roid hormone assays are not readily available [5]. 
Considering high mortality rates [4], medical 
treatment of TS should be initiated promptly and 
be aimed at treating the underlying condition, al-
leviating catecholamine-dependent mechanisms 
and peripheral effects of thyroid hormone excess, 
inhibiting new thyroid hormone synthesis and re-
lease, removing circulating thyroid hormones and 
enhancing thyroid hormone clearance [3, 6]. Acute 
thyrotoxicosis with abrupt onset of neurological 
symptoms and delirium precipitated by adminis-
tration of iodinated contrast media during CAG 
procedures has been previously reported [3]. Here, 
described for the first time as research indicates, 
is the unique case of a patient with recent-onset 
hyperthyroidism who developed acute delirium and 
confusional state caused by acute TS during emergent 
PCI for acute coronary syndrome. Our case highlights 
the critical importance of the prompt recognition and 
aggressive management of acute TS to prevent high 
risk of morbidity and mortality that may be associated 
with this alternative, life-threatening and potentially 
increasing cause of acute neurological manifestations 
in patients with hyperthyroidism undergoing PCI 
using iodinated contrast media.
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Figure 1. Temporal trends in circulating levels of free 
thyroid hormones.
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